Guillain-Barré syndrome presenting as mimicking croup

Shao-Hsuan Hsia1, Jainn-Jim Lin, Chang-Teng Wu

  • 1Divisions of Pediatric Critical Care and Emergency Medicine,Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.

Insights

Pediatric stridor can mimic croup but may signal rare conditions like Guillain-Barré syndrome (GBS). Early recognition of atypical GBS symptoms, including vocal cord paralysis, is crucial for timely management.

Area of Science:

  • Pediatric Neurology
  • Critical Care Medicine
  • Otolaryngology

Background:

  • Stridor is a common symptom of pediatric upper airway obstruction, often caused by infections like croup.
  • Less common etiologies of stridor require consideration in the differential diagnosis for accurate patient management.

Observation:

  • A 3-year-old girl presented with progressive hoarseness, barking cough, and dyspnea, initially resembling croup.
  • Following admission, she developed muscle weakness and areflexia, indicating a neurological compromise.
  • Flexible laryngoscopy revealed bilateral vocal cord paralysis, a critical finding in the airway assessment.

Findings:

  • The patient was diagnosed with Guillain-Barré syndrome (GBS), an autoimmune disorder affecting the peripheral nervous system.
  • Bilateral vocal cord paralysis was identified as an atypical presenting symptom of GBS in this pediatric case.
  • The clinical presentation initially mimicked common infectious causes of pediatric stridor.

Implications:

  • This case highlights the importance of considering neurological disorders, such as GBS, in the differential diagnosis of pediatric stridor.
  • Early identification of atypical GBS presentations, including vocal cord paralysis, is essential for prompt diagnosis and treatment.
  • Recognizing unusual symptoms of GBS can prevent diagnostic delays and ensure appropriate critical care interventions.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...